Sign in

CIK 0001824293

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

GRI Bio, Inc.

Sign in to watch
Ticker
GRI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
824369909
Phone
+1 619-400-1171
Business address
2223 AVENIDA DE LA PLAYA, SUITE 208, LA JOLLA, CA, 92037
Former names
Vallon Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-04 Baker David Charles Director Grant or award · Stock Option (Right to Buy) +3,935 3,935
2026-11-04 SIMPSON CAMILLA V Director Grant or award · Stock Option (Right to Buy) +3,935 3,935
2026-11-04 Rongen Roelof Director Grant or award · Stock Option (Right to Buy) +3,935 3,935
2026-11-04 Szekeres David Leslie Director Grant or award · Stock Option (Right to Buy) +6,558 6,558
2025-09-18 Chaturvedi Vipin Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +43,222 43,222
2025-09-18 Hertz Walter Marc Chief Executive Officer Grant or award · Stock Option (Right to Buy) +103,067 103,067
2025-09-18 Baker David Charles Director Grant or award · Stock Option (Right to Buy) +23,605 23,605
2025-09-18 SIMPSON CAMILLA V Director Grant or award · Stock Option (Right to Buy) +23,605 23,605
2025-09-18 Rongen Roelof Director Grant or award · Stock Option (Right to Buy) +23,605 23,605
2025-09-18 Szekeres David Leslie Director Grant or award · Stock Option (Right to Buy) +39,897 39,897
2025-09-18 Kelly Leanne Chief Financial Officer Grant or award · Stock Option (Right to Buy) +43,222 43,222
2025-08-26 Hertz Walter Marc Chief Executive Officer Grant or award · Stock Option (Right to Buy) +26,688 26,688
2025-08-26 Szekeres David Leslie Director Grant or award · Stock Option (Right to Buy) +10,276 10,276
2025-08-26 Baker David Charles Director Grant or award · Stock Option (Right to Buy) +5,994 5,994
2025-08-26 Rongen Roelof Director Grant or award · Stock Option (Right to Buy) +5,994 5,994
2025-08-26 Chaturvedi Vipin Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +11,854 11,854
2025-08-26 SIMPSON CAMILLA V Director Grant or award · Stock Option (Right to Buy) +5,994 5,994
2025-08-26 Kelly Leanne Chief Financial Officer Grant or award · Stock Option (Right to Buy) +11,854 11,854
2025-08-13 SIMPSON CAMILLA V Director Grant or award · Stock Option (Right to Buy) +4,527 4,527
2025-08-13 Baker David Charles Director Grant or award · Stock Option (Right to Buy) +4,527 4,527

Page 1 of 4 · 64 trades